Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

<p>Supplementary Table S8. DEGs for 6 months Comparison of CD49d+ and CD49d-</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Anfal Alsadhan (15907475) (author)
Diğer Yazarlar: Jonathan Chen (15907478) (author), Erika M. Gaglione (15032498) (author), Chingiz Underbayev (15907481) (author), Pamela L. Tuma (15907484) (author), Xin Tian (15907487) (author), Lita A. Freeman (15907490) (author), Sivasubramanian Baskar (15907493) (author), Pia Nierman (15907496) (author), Susan Soto (15907499) (author), Andy Itsara (15907502) (author), Inhye E. Ahn (15032501) (author), Clare Sun (14953020) (author), Elena Bibikova (15907505) (author), Tanja Nicole Hartmann (15907508) (author), Maissa Mhibik (15907511) (author), Adrian Wiestner (15907514) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
_version_ 1849927632375775232
author Anfal Alsadhan (15907475)
author2 Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Anfal Alsadhan (15907475)
Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
author_role author
dc.creator.none.fl_str_mv Anfal Alsadhan (15907475)
Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
dc.date.none.fl_str_mv 2025-11-25T13:26:57Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30709081
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Table_S8_from_CD49d_Expression_Identifies_a_Biologically_Distinct_Subtype_of_Chronic_Lymphocytic_Leukemia_with_Inferior_Progression-Free_Survival_on_BTK_Inhibitor_Therapy/30709081
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
dc.title.none.fl_str_mv Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Supplementary Table S8. DEGs for 6 months Comparison of CD49d+ and CD49d-</p>
eu_rights_str_mv openAccess
id Manara_fa70ffbad29c3a664ab1c1c32c8d68dc
identifier_str_mv 10.1158/1078-0432.30709081
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30709081
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor TherapyAnfal Alsadhan (15907475)Jonathan Chen (15907478)Erika M. Gaglione (15032498)Chingiz Underbayev (15907481)Pamela L. Tuma (15907484)Xin Tian (15907487)Lita A. Freeman (15907490)Sivasubramanian Baskar (15907493)Pia Nierman (15907496)Susan Soto (15907499)Andy Itsara (15907502)Inhye E. Ahn (15032501)Clare Sun (14953020)Elena Bibikova (15907505)Tanja Nicole Hartmann (15907508)Maissa Mhibik (15907511)Adrian Wiestner (15907514)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentImmuno-oncologyCell SignalingCell adhesionProtein tyrosine kinasesDrug ResistanceHematological CancersLeukemiasLymphomasImmunologyImmunomodulation<p>Supplementary Table S8. DEGs for 6 months Comparison of CD49d+ and CD49d-</p>2025-11-25T13:26:57ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709081https://figshare.com/articles/dataset/Supplementary_Table_S8_from_CD49d_Expression_Identifies_a_Biologically_Distinct_Subtype_of_Chronic_Lymphocytic_Leukemia_with_Inferior_Progression-Free_Survival_on_BTK_Inhibitor_Therapy/30709081CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307090812025-11-25T13:26:57Z
spellingShingle Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Anfal Alsadhan (15907475)
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
status_str publishedVersion
title Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_full Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_fullStr Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_full_unstemmed Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_short Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_sort Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
topic Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation